Why DaVita Inc. Sank Lower Today
Warren Buffett might like it, but DaVita (NYSE: DVA) was down 9.7% at 3:42 p.m. EDT, after an analyst at J.P. Morgan downgraded the kidney-dialysis company from neutral to underweight, citing legal battles as a reason to be skeptical of DaVita's prospects.
Earlier this year, DaVita and fellow dialysis company Fresenius Medical Care (NYSE: FMS) received subpoenas from the U.S. Department of Justice over their contributions to the American Kidney Fund, a charity that provides financial assistance for patients who need dialysis.
Image source: Getty Images.
Source: Fool.com
Fresenius Medical Care AG & Co KGaA ADR Aktie
19,40 €
-
Positive Stimmung für Fresenius Medical Care AG & Co KGaA ADR mit mehreren Buy- gegenüber Sell-Einschätzungen.
Für Fresenius Medical Care AG & Co KGaA ADR ergibt sich ein leicht positives Potenzial, angesichts eines Kursziels von 21 € im Vergleich zu 19.4 €.
